HRES 803 · 119th Congress · Health
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Bill Progress
1
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the House Committee on Energy and Commerce.(2025-10-10)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 803 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. RES. 803 Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 10, 2025 Mr. Rose (for himself, Mrs. Harshbarger, Mr. Carter of Georgia, Mr. LaMalfa, Mrs. Biggs of South Carolina, Mr. Moore of Alabama, Ms. Hageman, and Mr. Grothman) submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. Whereas the Obama administration expanded access to chemical abortion drugs by removing in-person administration requirements, eliminating requirements for prescribers to report serious adverse effects, and removing f…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (11)
11 Republicans